Thiamine is the coenzyme precursor behind the enzymes that turn carbohydrate, fat, and amino acids into usable cellular energy, and its deficiency produces some of the most dramatic, fastest-reversing syndromes in all of nutrition — from heart failure to a specific, preventable form of brain damage. It is also the supplement category with the most confusing form landscape on the market: at least six distinct chemical forms are sold as "vitamin B1," each with a genuinely different absorption route and evidence base, and the marketing claims about which one is "best absorbed" are more precise — and more overstated — than most pages let on. That comparison is the center of this page.
Thiamine (vitamin B1) is a water-soluble vitamin the body cannot synthesize and must obtain from diet or supplements. Its active form, thiamine pyrophosphate (TPP, also called thiamine diphosphate or cocarboxylase), is the obligate coenzyme for a small number of enzymes that sit at the entry points and critical junctions of carbohydrate, fat, and amino acid metabolism — meaning nearly all cellular ATP production depends on it somewhere upstream. Unlike most vitamins, the body's thiamine reserve is genuinely small and turns over quickly, which is why deficiency symptoms can appear within weeks of inadequate intake rather than months, and why thiamine deficiency remains a real, actively-studied clinical problem in specific populations despite fortified food supplies. Thiamine is also sold in more chemically distinct supplement forms than almost any other vitamin, each with a real, different absorption route — the subject of this page's central comparison.
Every benefit below is backed by a human RCT, meta-analysis, or authoritative fact sheet. Evidence strength is labeled honestly, including where a benefit is well-established only in deficient populations.
Benefits above describe what thiamine does in plain terms. These take a subset of the same topics deeper into trial design and the specific form used — which matters more for thiamine than for almost any other vitamin.
Thiamine's mechanisms are concentrated in a small number of enzymes that sit at critical junctions of energy metabolism — which is exactly why deficiency produces such disproportionately severe effects from such a small daily requirement.
Thiamine pyrophosphate is the obligate cofactor for pyruvate dehydrogenase, the enzyme complex that converts pyruvate (the end product of glycolysis) into acetyl-CoA, the entry point into the citric acid cycle. Without it, glucose-derived carbon cannot efficiently enter aerobic energy production. [1]
A second TPP-dependent enzyme complex within the citric acid cycle itself, converting alpha-ketoglutarate to succinyl-CoA. This is considered the rate-limiting step most sensitive to thiamine status, and its impairment is central to why brain energy metabolism fails first and fastest in deficiency. [9]
Transketolase, also TPP-dependent, links glycolysis to the pentose phosphate pathway, which generates NADPH for antioxidant defense and ribose-5-phosphate for nucleotide synthesis. Erythrocyte transketolase activity is the standard laboratory biomarker used to assess thiamine status. [10]
A fourth TPP-dependent enzyme, this one governs the catabolism of the branched-chain amino acids (leucine, isoleucine, valine), linking thiamine status to amino acid metabolism as well as carbohydrate and fat metabolism.
At low, dietary-range doses, thiamine crosses the small intestine primarily via saturable active transporters (THTR1/THTR2, encoded by SLC19A2/SLC19A3). At higher doses, a separate, non-saturable passive absorption route becomes the dominant pathway — the basis for why high-dose oral thiamine still raises blood levels substantially, addressed in full in Clinical Indications above. [7]
Beyond its coenzyme role, a minor thiamine phosphate ester (thiamine triphosphate) is concentrated in nerve tissue and implicated in neuronal membrane and ion-channel signaling independent of energy metabolism — part of why thiamine deficiency produces neurological symptoms that are not fully explained by energy failure alone. [11]
Thiamine is one of only seven nutrients with no established Tolerable Upper Intake Level — a genuinely different safety profile from most of the minerals covered elsewhere on this site.
| Life Stage / Context | RDA / Typical Dose | Tolerable Upper Limit | Notes |
|---|---|---|---|
| Adult men (19+) | 1.2 mg/day | Not established | Most U.S./Canadian adults meet this from diet and fortified grain products [12] |
| Adult women (19+) | 1.1 mg/day | Not established | 1.4 mg/day in pregnancy and lactation |
| Diabetic neuropathy trials (benfotiamine) | 150–600 mg/day | Not established | Supervised research contexts; not a self-directed target [5] |
| Wernicke's encephalopathy (clinical) | 500 mg IV, 3×/day | Not established | Emergency medical protocol, not self-directed supplementation [4] |
Why is there no Tolerable Upper Limit?
No toxicity from oral thiamine intake has been documented in the scientific literature, even at gram-level research and clinical doses. This puts thiamine alongside biotin, riboflavin, vitamin B12, and vitamin K as nutrients where excess intake hasn't been shown to cause harm. [13]
Does "no established UL" mean unlimited doses are a good idea?
No — it means toxicity hasn't been documented, not that megadosing is beneficial. Research and clinical doses above the RDA are used for specific, supervised indications (diabetic neuropathy trials, Wernicke's treatment), not as a general "more is better" rationale.
Thiamine supplement labels state elemental thiamine directly, so there's no compound-weight conversion needed — the real complexity is matching dose to absorption route, not doing unit math.
Same elemental dose, very different blood levels
A 100mg oral dose of thiamine hydrochloride and a 100mg-thiamine-equivalent dose of benfotiamine do not produce comparable blood thiamine — the difference comes entirely from absorption route, not from the amount of thiamine listed on the label.
Quick reference: reading a thiamine supplement label
Thiamine supplement labels state elemental thiamine (or thiamine-equivalent, for derivatives like benfotiamine) directly in milligrams — there's no separate compound-weight conversion needed, unlike minerals such as magnesium or calcium. The mg figure on the label is what counts toward the RDA, but as the comparison above shows, the same mg figure does not mean the same blood level across different forms — see Form Comparison, below, for the full picture.
No other common vitamin is sold in this many chemically distinct forms with genuinely different pharmacokinetics. Each one below is evaluated on its own evidence, not ranked by absorption number alone.
| Form | Solubility | Absorption Route | Relative Blood Bioavailability | Notable Strength |
|---|---|---|---|---|
| Thiamine HCl | Water-soluble | Active transport + passive (high dose) | Reference (1×) | Largest evidence base for deficiency correction |
| Thiamine Mononitrate | Water-soluble | Same as HCl | ~Equivalent to HCl | Shelf stability for food fortification |
| Benfotiamine | Lipid-soluble (thioester) | Passive diffusion | ~11× plasma vs. HCl [14] | Highest blood/peripheral tissue levels; not brain-specific |
| Sulbutiamine | Lipid-soluble (disulfide dimer) | Passive diffusion, crosses BBB readily | Higher than HCl; brain-favoring | Best central nervous system penetration |
| Allithiamine / TTFD | Lipid-soluble (disulfide) | Passive diffusion | Higher than HCl, lower than benfotiamine [20] | Longest clinical-use history among lipid-soluble forms |
| TPP / Cocarboxylase | Water-soluble | Must be dephosphorylated first, same as others | No established oral advantage | Used by injection in specific clinical contexts |
The practical takeaway
"Best absorbed" isn't a single answer for thiamine — it depends on which tissue you're trying to reach. Benfotiamine wins on blood and peripheral tissue levels; sulbutiamine wins on brain penetration; thiamine HCl remains the best-evidenced choice for correcting a diagnosed deficiency, partly because nearly the entire deficiency-disease literature was built on it. The right form is the one matched to the actual goal, not the one with the highest bioavailability number on a product label.
Thiamine's metabolism connects directly to magnesium, to the other energy-metabolism B vitamins, and to a specific carbohydrate-refeeding interaction that can be clinically dangerous.
| Nutrient | Interaction Type | Mechanism | Clinical Relevance | Evidence Quality |
|---|---|---|---|---|
| Magnesium | TPP Requires Mg | Thiamine pyrophosphate functions as an enzyme cofactor only when bound to magnesium; the biologically active form is technically the Mg-TPP complex, not TPP alone. [9] | High mechanistically: magnesium deficiency can blunt the functional benefit of thiamine repletion even when thiamine levels look adequate, which is a genuinely underused clinical point in refeeding contexts. | Established enzyme biochemistry |
| Carbohydrate Intake (Refeeding) | Depletion Risk | Reintroducing carbohydrate after prolonged fasting or malnutrition sharply increases demand for TPP-dependent enzymes, and can precipitate acute thiamine deficiency (refeeding syndrome) in someone with marginal stores. [22] | High in malnourished, post-bariatric-surgery, or prolonged-fasting patients: thiamine is given before or alongside refeeding in these populations for this specific reason. | Well-documented clinical syndrome |
| Vitamin B6 & B2 (Riboflavin) | Complementary | Riboflavin (as FAD) and thiamine (as TPP) both participate in overlapping mitochondrial energy-metabolism pathways, including the pyruvate dehydrogenase complex, which also uses FAD as a cofactor. [1] | Low-Moderate: relevant to why B-complex formulations bundle these together, though no RCT establishes an added clinical benefit from combining them over correcting either deficiency alone. | Established biochemistry, limited combined-supplementation trials |
| Folate & Vitamin B12 | Overlapping Deficiency Risk | No direct biochemical interaction with thiamine's coenzyme function, but the same populations at risk of thiamine deficiency (alcohol use disorder, malabsorption, bariatric surgery) are frequently deficient in these nutrients too. [2] | Moderate: a practical, population-overlap relevance rather than a direct metabolic interaction. | Epidemiological co-occurrence |
⚠ The refeeding-magnesium-thiamine triad
This is a genuinely underused clinical connection: giving thiamine without checking magnesium status in a refeeding or malnourished patient can leave the functional deficiency partly uncorrected, because the active Mg-TPP complex requires both. [9] This is a reason clinical refeeding protocols increasingly check and correct magnesium alongside thiamine, not a general supplementation recommendation for the healthy public.
Thiamine deficiency is rare in the general population eating a varied, fortified diet. These are the groups where it's a genuine, actively-managed clinical concern.
The single most common cause of thiamine deficiency in developed countries, driven by low dietary intake, impaired intestinal absorption, and reduced liver storage capacity — the population in whom Wernicke-Korsakoff syndrome is most often diagnosed. [4]
Furosemide and other loop diuretics measurably increase urinary thiamine loss, contributing to the elevated deficiency rates seen in this population (see Drug Interactions, below). [23]
Reduced intake and altered absorption after bariatric procedures create a well-documented, ongoing thiamine deficiency risk requiring monitoring and often lifelong supplementation.
Severe, prolonged vomiting in pregnancy can rapidly deplete the body's small thiamine reserve, creating real risk of Wernicke's encephalopathy in pregnancy if unrecognized.
A genuine obstetric emergency risk, not routine morning sicknessIncreased metabolic demand and reduced intake in critical illness are associated with thiamine deficiency, and thiamine has been studied as an adjunct therapy in septic shock protocols. [24]
Anyone resuming normal caloric or carbohydrate intake after a prolonged period of starvation or severe restriction is at risk for refeeding syndrome, in which thiamine is given proactively before or alongside nutrition resumes. [22]
Two well-documented interactions, both relevant to populations already flagged above as higher-risk for deficiency.
| Drug / Drug Class | Direction | Mechanism | Recommendation |
|---|---|---|---|
| Loop diuretics (e.g., furosemide) | Increases thiamine excretion | Loop diuretics measurably increase urinary thiamine loss, contributing to deficiency risk in chronically diuretic-treated patients, notably in heart failure. [23] | Long-term loop diuretic users, especially with heart failure, should discuss thiamine status monitoring with their prescriber. |
| 5-Fluorouracil (chemotherapy) | Accelerates thiamine depletion | 5-FU interferes with thiamine-dependent metabolic pathways and has been linked to acute Wernicke's-like encephalopathy in case reports, thought to be precipitated by drug-induced thiamine depletion. [25] | Oncology teams monitor for this; not a reason for self-directed supplementation without medical guidance during chemotherapy. |
Answers to the specific form, dosing, and safety questions most often raised about thiamine.
Numbered references for every claim made on this page, drawn from peer-reviewed literature and NIH fact sheets.